Medindia

X

Dr. Ayoub Sayeg Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

Friday, September 18, 2009 General News J E 4
Advertisement


TROY, Mich., Aug. 10 Dr. Ayoub Sayeg, director of Sayeg Plastic Surgery Center, has selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines, to treat patients who are looking for a longer lasting dermal filler. Dr. Sayeg has been an avid practioner of Artefill the past several years due to its proven success and effectiveness for the correction of wrinkles.

"I have used many fillers on my patients, but none have measured up to the consistency and reliability of Artefill," said Dr. Sayeg. He went on to say, "Artefill's longevity makes it a smart investment and the patient results have been magnificent to say the least."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Artefill is only offered by a select group of physicians in Michigan and is not available at all physician offices. Dr. Sayeg is one of the company trained and select few company sponsored physicians who has the skills and experience needed to administer the product.

Craig Najar, an Artefill patient of Dr. Sayeg's said, "I was never pleased with my deep, nasolabial folds and a "mid face lift" didn't correct them. Web surfing led me to Artefill and Dr. Sayeg. He and his staff were very pleasant, professional and after just one injection with Artefill my folds were finally gone. What seemed to be an expensive treatment option was really a very low cost procedure. It's fast, effective, and long lasting. I would recommend Artefill to anyone seeking a long lasting solution to the 'parentheses' around their mouth!"

About Artefill:

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10 thousand patients have been treated successfully with very high satisfaction rates.

Suneva Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets, markets and manufactures Artefill. The Company was formed in April 2009 to deliver the same great product that physicians and patients have embraced over the past several years. For more information visit http://www.artefill.com/content/c/whatisartefill/overview.asp or www.sunevamedical.com.

About Sayeg Plastic Surgery:

The Sayeg Plastic Surgery Center in Troy, Michigan offers the latest cosmetic surgery procedures in the complete comfort and confidentiality of their state-of-the-art facility. They offer patients the procedures they want or need, help them meet or exceed their expectations, and provide services in affordable terms. The facility is located at 1120 E. Long Lake Road Troy, Michigan. They can be reached at 248-526-9090 and their website is www.yournewlooks.com.

Contact: Warren David Tel: 313-999-6000 warrend@davidcomgroup.com

SOURCE Sayeg Plastic Surgery Center
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Enobia Raises US$50M from Current Investors in Ser...
S
Sunshine Heart Implants First Female C-Pulse Patie...